Analyst consensus rating
Kestra Medical Technologies Analyst Rating: Strong Buy
Direct answer
Kestra Medical Technologies's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.13.
Forecast evidence checked November 12, 2026.
Get free Kestra Medical Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.63
- Average price target
- $31.13
- High price target
- $34.00
- Low price target
- $28.00
- Low target gap
- -11.5%
- Target upside
- -1.6%
- High target gap
- +7.5%
- Target range width
- 19%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Kestra Medical Technologies?
Kestra Medical Technologies has a verified Strong Buy consensus. The same dataset has an average price target of $31.13.
How far are Kestra Medical Technologies's low and high targets from the recorded price?
The low target implies -11.5%, while the high target implies +7.5%.
How many analysts are included in Kestra Medical Technologies's consensus?
The verified consensus includes 8 analysts.
How is Kestra Medical Technologies's target upside or downside calculated?
The average target of $31.13 is divided by the recorded price of $31.63, then one is subtracted to produce -1.6%. This does not guarantee a future return.
When was Kestra Medical Technologies's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.